跳至主要内容
临床试验/CTRI/2023/07/055723
CTRI/2023/07/055723尚未招募4 期

A Clinical Study to Evaluate the Safety and Efficacy of Panchakarma Essential in male patients with generalized anxiety disorder - NI

Mprex Healthcare Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male subjects 30-60 years of age will be included.2.Male Subjects with no history of allergy to oils.3.Be willing to refrain from taking any medication during or before the study for the said indication.4.An ambulatory subject can provide verbal and written consent and is ready to comply with all study procedures.

排除标准

  • 1. Male Subjects with Depression, Social phobias, Hypertension, Cardiac diseases, Epilepsy, Asthma, Hyperthyroidism, Alcoholics, and Drug addicts
  • 2. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.

研究者

相似试验